Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Seen some posts on Twitter showing a big director of Beckman Coulter commenting on David Buds post regarding the collaboration. He seems pretty upbeat about things so maybe some good plans of decent scale are taking shape behind the scene?
Hopefully we will now see a stream of positive News, coming from various quarters. Feeling very upbeat right now.
Sattara , thanks , just read it "planning something BIG " news soon several fronts, getting exciting now for sure
Link?
Ive been trying to find Genedrive or David Budd on twitter, what do you search for?
Gap and go in the morning
Retrace and gap now closed.
Expecting a blue finish again today. Haven't yet consulted chart this morning but will do later
Search #gdr
The hasgtag is the trend. Gdr is the stock code. Then filter by latest posts first.
Coldspy, those lottery numbers please! :-)
Livinhope it's just the MM's are predictable :)
Camelot isn't unfortunately
Interestingly, if you are on LinkedIn - look at the people in Beckman who have 'liked' Steves post about this collaboration. They are in Tokyo, France, Australia, USA. Some of them have also shared other Genedrive posts. It certainly shows momentum building at Beckman.
It doesn't just look like Steve is the only one excited by this.
Livinhope it's just the MM's are predictable :)
Camelot isn't unfortunately
=====
Damn, was hoping to be able to retire after the weekend! My experience of the MMs here is that they are indeed predictable...always wanting to pull the sp down!
It is big, if everything pans out as we expect this will provide a fully integrated system, automated extraction and test. It would jump ahead of others because Beckman can offer the complete solution and a very easy format, reducing errors and maximising sensitivity as only the sample needs to be added. It also shortens the processing time and limits chances of pipetting errors as you're only pipetting one thing.... sample.
For GDR it provides world wide market access. For Beckman it provides a world class diagnostic.
I'm 100% they will take as many as we can manufacture, an update on that front would be very nice now.
Where’s this golden cross. Take off thingy gone
i wonder what machines DIVOC are using?
my guess is Beckman :)
wouldn't that be sweet
Dave77, most of the links being referred to e.g. Dave Budd is on LinkedIn
One thing is for sure. If Beckman and GDR get this testing setup right it will most certainly get taken up across the world. It saves money, increases output and more importantly is accurate and error free. Automation is the way and with DIVOC also setting up a lab i wouldn't be surprised to see all this joining up to be a massive jigsaw puzzle using thousands of test kits every day across the globe. Let's hope David can pull it off, he's certainly got the right experience and right team with him to get this job done amazingly.
Ok so to bring some light on the BC partnership.... this is just my view and not something ive verified with GDR or BC.
I dont think we will hear from that area until the validation is complete, but its not all bad, our news flow could be in full flow come the end of the month and that would literally end up being the cherry on the cake if all the other news are good too.
Its important to note GDR have adapted their test (now uses Saliva) to make it work using Beckman Coulter's RNAdvance viral extraction chemistry. Thats a huge thing. We just did an upgrade on the test.
BC need to validate it, with the claims that the test performs xyz in abc working environments. And that their robots can work using the test.
Now the yanks are a funny bunch, some analysts say they need to do 30m tests a day, some day 900k a day, some say 3m a day. I dont know how the lab would work, do BC staff collect samples in a drive thru? do people mail in? do they just act as a high throughput lab where other labs and sample collection services send them samples and BC mass test. Are these free gov funded tests?
I am hoping for the latter coupled with being a central lab that does high throughput processing for others. One lab, if profitable could be lots of labs.
This is an educated guess.
Ty, don’t use LinkedIn, only started using Twitter about 3 month ago.
i am not sure they have changed the test i think they just use Beckmans RNA extraction procedure which works on saliva. I will have a read and see what i can find.
Any major changes to the test would require more approvals and we have had no notification of those i think.
also Beckmans have a branch in Dehli :)
@Grim
You're probably right mate, either way its Saliva now and not invasive swab which brings its own problems especially when not done correctly :-)
Saliva is much easier to get a sample and less likely to have a error in collection but has less of a viral load than the samples from Buccal swabs. Buccal swabs are horrid to take and can cause discomfort where as spitting in a tube is relatively easy and most, even some people on here should be able to do it without too much of an issue. :)
you are right though its is now saliva and that is another improvement.
For the future this connection of GDR and Beckman has huge potential. The number of other tests which could be automated using this tech and Genedrive's testing beads format could revolutionise lab based diagnostics, but like everything GDR, potential needs to be converted to hard cash in the bank at some point or all is for nought. (way to many commas in that sentence). :)
All this ****ting news and we’re still not to the £1 mark. Who’s selling bgf or placement. Can’t be much left. Would be flushed out by vol